(NASDAQ: CLPT) Clearpoint Neuro's forecast annual revenue growth rate of 28.46% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 7.09%, and it is also forecast to beat the US market's average forecast revenue growth rate of 11.9%.
Clearpoint Neuro's revenue in 2025 is $33,593,000.On average, 1 Wall Street analysts forecast CLPT's revenue for 2025 to be $1,088,770,071, with the lowest CLPT revenue forecast at $1,088,770,071, and the highest CLPT revenue forecast at $1,088,770,071. On average, 1 Wall Street analysts forecast CLPT's revenue for 2026 to be $1,429,899,075, with the lowest CLPT revenue forecast at $1,429,899,075, and the highest CLPT revenue forecast at $1,429,899,075.
In 2027, CLPT is forecast to generate $2,097,943,375 in revenue, with the lowest revenue forecast at $2,097,943,375 and the highest revenue forecast at $2,097,943,375.